CRISPR Gene-Editing Tool Used To Treat First U.S. Patient
For the first time in the U.S., a patient has received an infusion of 2 billion cells edited with the gene-editing tool CRISPR to help treat sickle cell disease, presaging a new age of targeted treatments for genetic diseases. What do you think?
Alysha Phelps
Would it really have been that hard to figure out a way to add an 'e' to the acronym?
Infomercial Extra